Takuva S, Takalani A, Seocharan I, Yende-Zuma N, Reddy T, Engelbrecht I, et al. Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial. PLoS Med. 2022;19(6):e1004024. https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004024&type=printable
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
By Peter Matlawa|2023-04-17T15:04:34+02:00April 17, 2023|2022: April to June|Comments Off on Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
Share This Story, Choose Your Platform!
About the Author: Peter Matlawa
Related Posts
Antimicrobial susceptibility and genomic profiling of Salmonella enterica from bloodstream infections at a tertiary referral hospital in Lusaka, Zambia, 2018-2019.